Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.

Roberta D'AmbrosioGiuliano RizzardiniMassimo PuotiStefano FagiuoliMaria Paola AnolliClaudia GabiatiFederico D'AmicoLuisa PasuloUmberto RestelliMassimo ColomboPietro Lampertico

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

This pivotal study demonstrated the feasibility of a POC-based anti-HCV screening programme in young adults undergoing COVID-19 vaccination. The prevalence of HCV infection in subjects born in the 1969-1989 cohort in Italy seems to be lower than previously estimated. Whether the extension of this programme to subjects born before 1969 could lead to improved screening effectiveness should be a matter of debate.

Keyphrases

hepatitis c virus
coronavirus disease
young adults
sars cov
human immunodeficiency virus
randomized controlled trial
healthcare
study protocol
primary care
low birth weight
gestational age
systematic review
risk factors
clinical trial
preterm infants
quality improvement
antiretroviral therapy